Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

UK Gastrointestinal Remedies market report

Everything you need to make the right decisions

Providing the most comprehensive and up-to-date information and analysis of the Gastrointestinal Remedies market, its consumers and the major players who make up that market.

Market

Point of sale market data

In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on

Market Size

How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios

Market Segmentation

What are the different segments within the market and how are those individual segments performing?

Consumer

Consumer behaviors

What are consumers looking for, what drives their buying habits and what are their main purchase influencers?

Demographic breakdown

From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?

Representative sample

We gather our data from real-world consumers, selected to accurately reflect precise global demographics

Players

Company strategy

What are the key players doing, what has been successful for them and what was their marketing spend?

Product innovation

Using data from our Global New Product Database, what products were launched and how well were they perceived?

Opportunities

What happens next, which areas are likely to experience growth and what opportunities exist within the market?

Expert analysis from a specialist in the field

Written by Jack Duckett, a leading analyst in the Healthcare sector, his extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.

Sales of gastrointestinal remedies have surged in recent years as consumers have become increasingly aware of their diet and digestive health. However, along with a growing awareness of health issues comes a greater desire to treat illness through dietary changes rather than reaching for medications, which is a challenge for the market in years to come. Falling investment in NPD (New Product Development) is also likely to impact consumer engagement, which could in turn lead to a downturn in sales, highlighting the importance of innovation to the category. Jack Duckett
Research Analyst

Mintel has the answers you’re looking for

What are the key challenges facing the industry and how fast are its rates of growth? Who is the consumer and what do they want? Where are the opportunities, where are the risks and what lies ahead?

This report discusses the following key topics:

Products covered in this Report

This Report analyses the market for all types of indigestion and stomach remedies available over the counter, which together constitute the gastrointestinal (GI) remedies market.

The five main categories are as follows:

  • Indigestion/heartburn remedies range from simple antacids such as Rennie or wind relief such as Setlers or Wind-eze to more potent medication such as Gaviscon or Zantac.
  • Laxatives relieve constipation and work in one of several ways, either by introducing fibre to the bowel, stimulating the bowel or softening stools.
  • Anti-diarrhoeals are usually opiate-based to slow down the movement of waste through the bowel, and/or contain kaolin to add bulk to waste and neutralise bacteria. This segment also includes rehydrating solutions, or electrolyte solutions, which replace the fluid and salts lost when suffering from diarrhoea.
  • Stomach upset remedies, for example, Alka-Seltzer or Andrews, relieve general nausea and settle the stomach.
  • IBS (Irritable Bowel Syndrome) products provide symptomatic relief for the spasms and bloating which are typical of IBS. Many of these products, such as Colpermin, are based on peppermint oil, which is naturally soothing for gastrointestinal problems.

This Report covers only over-the-counter (OTC) (non-prescription) medication, defined by the Proprietary Association of Great Britain as being:

“Specifically designed to treat the symptoms of common, minor and self-limiting ailments that do not require a medical diagnosis.”

They are divided into two categories:

P: Pharmacy-only products, which can only be sold through pharmacies by, or in the presence of, a qualified pharmacist.

GSL: General Sales List, which can be sold in any type of outlet.

Prescription-only Medicines (POMs), which have to be prescribed by a GP (General Practitioner) and dispensed by a qualified pharmacist, are not included within the scope of this Report.

What you need to know

The UK gastrointestinal (GI) remedies market enjoyed 3% growth in value sales in 2015, rising from £281 million in 2014 to £288 million in 2015, driven by strong sales of upset stomach and irritable bowel syndrome remedies, as well as indigestion treatments.

Going forward, however, increased consumer emphasis on healthy eating could see more people look for dietary solutions to their GI ailments, lessening demand for targeted remedies. As such, brands could benefit from product innovation and marketing to help promote a more holistic approach to health.

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Overview

    • What you need to know
      • Products covered in this Report
      • Executive Summary

          • GI remedies market enjoys strong value sales growth
            • Figure 1: Best- and worst-case forecast of UK value sales of gastrointestinal remedies, 2010-20
          • Launch activity tumbles
            • Figure 2: New product launches in the gastrointestinal remedies market, by launch type, 2012-15
          • Treating GI health issues
            • Figure 3: Experience of gastrointestinal health problems and treatments used, February 2016
          • Stress proves leading cause of GI health problems
            • Figure 4: Factors contributing to experience of GI problems in the last 12 months, February 2016
          • Controlling GI problems with diet
            • Figure 5: Attitudes towards treating GI health problems, February 2016
          • GI preparation limited
            • Figure 6: Attitudes towards GI remedies, February 2016
          • What we think
          • Issues and Insights

            • Driving usage through preparatory purchases
              • The facts
                • The implications
                  • Stimulating growth through brand extension
                    • The facts
                      • The implications
                        • Digital educational initiatives
                          • The facts
                            • The implications
                            • The Market – What You Need to Know

                              • GI remedies market enjoys strong value sales growth
                                • Indigestion remedies drive market growth
                                  • Supermarkets and chemists dominate sales
                                    • Baby boom slows
                                      • GI prescriptions continue to rise
                                        • Healthy eating boom
                                          • Indigestion remedies linked to dementia
                                          • Market Size and Forecast

                                            • GI remedies market enjoys strong value sales growth
                                              • Figure 7: UK retail value sales of gastrointestinal remedies, at current and constant prices, 2010-20
                                            • Innovation could boost category
                                              • Figure 8: Best- and worst-case forecast of UK value sales of gastrointestinal remedies, 2010-20
                                          • Segment Performance

                                            • Indigestion remedies drive market growth
                                              • Figure 9: UK retail value sales of gastrointestinal remedies, by segment, 2014-15
                                            • Sales of IBS remedies continue to grow
                                            • Channels to Market

                                              • Supermarkets and chemists dominate sales
                                                  • Figure 10: UK retail value sales of gastrointestinal remedies, by outlet type, 2014-15
                                                • Discounters continue to grow share
                                                • Market Drivers

                                                  • Ageing population
                                                    • Figure 11: Trends in the age structure of the UK population, 2010-20
                                                  • Baby boom slows
                                                    • Figure 12: Trends in the number of live births, England and Wales, 2004-14
                                                  • GI prescriptions continue to rise
                                                    • Figure 13: Number of gastrointestinal prescription items dispensed, 2009-14
                                                  • War on sugar
                                                    • Figure 14: Daily added (free) sugar intake, by age, UK, rolling programme 2008-12
                                                  • Healthy eating gathers more momentum
                                                    • Foreign travel declines in 2015
                                                      • Figure 15: UK residents’ visits abroad, by month, December 2013-December 2015
                                                    • Indigestion remedies linked to dementia
                                                    • Key Players – What You Need to Know

                                                      • Own-label continues to claw share from independent brands
                                                        • Launch activity tumbles
                                                          • Brands continue to grow share of NPD
                                                            • Botanical claims signal shift towards natural
                                                              • Pfizer launches Nexium Control product
                                                                • Exploring alternative advertising channels
                                                                • Market Share

                                                                  • Own-label continues to claw share from independent brands
                                                                    • Figure 16: UK retail value sales of gastrointestinal remedies, by brand, years ending January 2015 and 2016
                                                                  • Gaviscon dominates value sales
                                                                  • Launch Activity and Innovation

                                                                    • Launch activity tumbles
                                                                      • Figure 17: New product launches in the gastrointestinal remedies market, by launch type, 2012-15
                                                                    • Ingestible remedies dominate GI market
                                                                      • Figure 18: New product launches in the gastrointestinal remedies market, by format type, 2012-15
                                                                    • Brands continue to grow share of NPD
                                                                      • Figure 19: New product launches in the gastrointestinal remedies market, branded vs own-label, 2012-15
                                                                    • Botanical claims signal shift towards natural
                                                                    • Brand Communication and Promotion

                                                                      • Boom in advertising spend
                                                                        • Figure 20: Total above-the line, online display and direct mail advertising expenditure on gastrointestinal remedies, 2012-15
                                                                      • Alternative advertising channels
                                                                        • Figure 21: Total above-the line, online display and direct mail advertising expenditure on gastrointestinal remedies, by media type, 2012-15
                                                                      • Reckitt Benckiser leads adspend in GI category
                                                                        • Figure 22: Total above-the line, online display and direct mail advertising expenditure on gastrointestinal remedies, by top 10 advertisers, 2012-15
                                                                      • Nielsen Ad Intel coverage
                                                                      • Brand Research

                                                                          • Brand map
                                                                            • Figure 23: Attitudes towards and usage of selected brands, March 2016
                                                                          • Key brand metrics
                                                                            • Figure 24: Key metrics for selected brands, March 2016
                                                                          • Brand attitudes: Gaviscon scores highly for quality
                                                                            • Figure 25: Attitudes, by brand, March 2016
                                                                          • Brand personality: Rennie suffers “tired” brand image
                                                                            • Figure 26: Brand personality – Macro image, March 2016
                                                                          • Boots Pharmaceuticals seen as classic
                                                                            • Figure 27: Brand personality – Micro image, March 2016
                                                                          • Brand analysis
                                                                            • Gaviscon enjoys almost universal awareness
                                                                              • Figure 28: User profile of Gaviscon, March 2016
                                                                            • 83% would recommend Imodium
                                                                              • Figure 29: User profile of Imodium, March 2016
                                                                            • Boots Pharmaceuticals proves most trusted brand
                                                                              • Figure 30: User profile of Boots Pharmaceuticals, March 2016
                                                                            • Rennie brand could benefit from product innovation
                                                                              • Figure 31: User profile of Rennie, March 2016
                                                                            • Senokot proves less well known
                                                                              • Figure 32: User profile of Senokot, March 2016
                                                                            • Opportunities for Buscopan to shed niche image
                                                                              • Figure 33: User profile of Buscopan, March 2016
                                                                          • The Consumer – What You Need to Know

                                                                            • Experience of GI health issues
                                                                              • Young adults turn to diet to fix their GI issues
                                                                                • Stress proves leading cause of GI health problems
                                                                                  • 16-24s most prone to viral gastrointestinal ailments
                                                                                    • Further opportunities for food education
                                                                                      • Responsibility for buying GI remedies
                                                                                        • GI preparation limited
                                                                                          • Branded vs own-label
                                                                                            • GI education
                                                                                            • Experience of GI Ailments and Treatments Used

                                                                                              • Experience of GI health issues
                                                                                                • Figure 34: Experience of gastrointestinal health problems in the past 12 months, February 2016
                                                                                              • Experience by age
                                                                                                • Figure 35: Experience of gastrointestinal health problems in the past 12 months, by age, February 2016
                                                                                              • Women more likely to experience GI issues
                                                                                                • Figure 36: Experience of gastrointestinal health problems, by gender, February 2016
                                                                                              • Treating GI health issues
                                                                                                • Figure 37: Experience of gastrointestinal health problems and treatments used, February 2016
                                                                                              • Young adults turn to diet to fix their GI issues
                                                                                                • Figure 38: Proportion of adults using diet to treat experience of gastrointestinal health problems, by age, February 2016
                                                                                            • Factors Contributing to Experience of GI Problems

                                                                                              • Stress proves leading cause of GI health problems
                                                                                                • Figure 39: Factors contributing to experience of GI problems in the last 12 months, February 2016
                                                                                              • Over a quarter of sufferers cite poor diet as a cause
                                                                                                • Figure 40: Proportion of adults citing “poor diet” as a cause of GI problems in the last 12 months, by gender and age, February 2016
                                                                                              • Young adults prove most prone to viral gastrointestinal ailments
                                                                                                • Figure 41: Proportion of adults who cite a virus as a factor behind their experience of GI problems in the last 12 months, by age, February 2016
                                                                                            • Attitudes towards Treating GI Problems

                                                                                              • Controlling GI problems with diet
                                                                                                • Figure 42: Attitudes towards treating GI health problems, February 2016
                                                                                              • A natural approach
                                                                                                • Figure 43: Attitudes towards treating GI health problems (continued), February 2016
                                                                                              • Boosting trust in exercise as a remedy
                                                                                                • Figure 44: Attitudes towards exercise to treat GI health problems, February 2016
                                                                                            • Shopping for GI Remedies

                                                                                              • Responsibility for buying GI remedies
                                                                                                • Figure 45: Proportion of adults who have bought GI remedies in the last 12 months, by gender, February 2016
                                                                                              • Purchase channel
                                                                                                • Figure 46: Channels used to purchase GI remedies in the last 12 months, February 2016
                                                                                            • General Attitudes towards GI Remedies

                                                                                              • GI preparation limited
                                                                                                • Figure 47: Attitudes towards accessibility of GI remedies, February 2016
                                                                                              • Encouraging young adults to stock up on GI remedies
                                                                                                • Figure 48: Selected attitudes towards GI remedies, by age, February 2016
                                                                                              • Branded vs own-label
                                                                                                • Figure 49: Attitudes towards selecting GI remedies, February 2016
                                                                                              • GI education
                                                                                                • Figure 50: Attitudes towards treating GI issues, February 2016
                                                                                            • Appendix – Data Sources, Abbreviations and Supporting Information

                                                                                                • Abbreviations
                                                                                                  • Consumer research methodology
                                                                                                    • Forecast methodology
                                                                                                      • Brand research
                                                                                                        • Brand map
                                                                                                          • Correspondence analysis
                                                                                                          • Appendix – The Market

                                                                                                              • Figure 51: UK retail value sales of gastrointestinal remedies, by segment, 2013-15
                                                                                                          • Appendix – Key Players

                                                                                                            • Indigestion remedies
                                                                                                              • Figure 52: UK retail value sales of indigestion remedies, by brand, years ending January 2015 and 2016
                                                                                                            • Anti-diarrhoeals
                                                                                                              • Figure 53: UK retail value sales of diarrhoea remedies, by brand, years ending January 2015 and 2016
                                                                                                            • Laxatives
                                                                                                              • Figure 54: UK retail value sales of laxatives, by brand, years ending January 2015 and 2016
                                                                                                            • Stomach upset remedies
                                                                                                              • Figure 55: UK retail value sales of stomach upset remedies, by brand, years ending January 2015 and 2016
                                                                                                            • Irritable bowel syndrome remedies
                                                                                                              • Figure 56: UK retail value sales of IBS remedies, by brand, years ending January 2015 and 2016